Search
for
Sort by
Research 481–510 of 1000+
- Beyond the follicle
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment
- CURRENT UNDERSTANDING OF VITILIGO: A COMPREHENSIVE LITERATURE REVIEW
- Björnstad Syndrome With Late‐Onset Alopecia Mimicking Androgenetic Alopecia: Histopathological and Genetic Findings
- “<i>Nomen Omen</i>: The Myth of God Janus”
- To Treat or Not to Treat: Two Roads Traveled With Alopecia Areata
- Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series
- BH14 Irish dermatologists’ experience with Janus kinase inhibitors in alopecia areata
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
- Alopecia Areata and Systemic Lupus Erythematosus: Insights From a Nationwide Case–Control Study
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- Baricitinib as a treatment for myasthenia gravis: A case report
- Editorial: Targeted immunological therapies in dermatology
- Modern dermatology brings treatment even for alopecia areata
- The Frontal Fibrosing Alopecia Treatment Dilemma
- Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study
- mTOR signaling in hair follicle and hair diseases: recent progress
- Survey of pediatric dermatologist views on treatment for alopecia areata
- Skin Biology and Ageing
- Pattern hair loss distribution: a novel presentation for alopecia areata
- Iron Screening in Alopecia Areata Patients May Catch Hereditary Hemochromatosis Early
- 022 Exploring the potential of the novel IFNγ aptamer TAGX-0003 as a treatment for alopeciaareata in pre-clinical models
- 50-Year-Old Female with a Burning Scalp and Hair Loss
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Alopecia Areata: Current Treatments and New Directions
- Resident Memory T Cells in Autoimmune Skin Diseases
- Treatment of pediatric alopecia areata: A systematic review